Potent and selective neuropeptide FF (NPFF) receptor antagonist. RF9 (1-Adamantanecarbonyl-Arg-Phe-NH₂) blocked the delayed and long-lasting paradoxical opioid-induced hyperalgesia and prevented the development of associated tolerance. RF9 could also efficiently block the increase in blood pressure and heart rate evoked by NPFF.